188 related articles for article (PubMed ID: 20069435)
1. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Bossaer JB; Hall PD; Garrett-Mayer E
Support Care Cancer; 2010 Feb; 19(2):231-7. PubMed ID: 20069435
[TBL] [Abstract][Full Text] [Related]
2. Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.
Kamboj M; Cohen N; Huang YT; Kerpelev M; Jakubowski A; Sepkowitz KA; Papanicolaou GA; Seo SK
Biol Blood Marrow Transplant; 2019 Mar; 25(3):594-598. PubMed ID: 30448456
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
Snyder M; Pasikhova Y; Baluch A
Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
[TBL] [Abstract][Full Text] [Related]
5. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
Chuang YC; Wang JT; Lin HY; Chang SC
BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
[TBL] [Abstract][Full Text] [Related]
7. Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp.
Lisboa LF; Miranda BG; Vieira MB; Dulley FL; Fonseca GG; Guimarães T; Levin AS; Shikanai-Yasuda MA; Costa SF
Int J Infect Dis; 2015 Apr; 33():171-6. PubMed ID: 25660090
[TBL] [Abstract][Full Text] [Related]
8. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH
BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Patel R; Gallagher JC
Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.
Poutsiaka DD; Skiffington S; Miller KB; Hadley S; Snydman DR
J Infect; 2007 Jun; 54(6):567-71. PubMed ID: 17188750
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.
Balli EP; Venetis CA; Miyakis S
Antimicrob Agents Chemother; 2014; 58(2):734-9. PubMed ID: 24247127
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.
Twilla JD; Finch CK; Usery JB; Gelfand MS; Hudson JQ; Broyles JE
J Hosp Med; 2012 Mar; 7(3):243-8. PubMed ID: 22076962
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
Roghmann MC; McCarter RJ; Brewrink J; Cross AS; Morris JG
Clin Infect Dis; 1997 Nov; 25(5):1056-9. PubMed ID: 9402356
[TBL] [Abstract][Full Text] [Related]
18. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
Matar MJ; Tarrand J; Raad I; Rolston KV
Am J Infect Control; 2006 Oct; 34(8):534-6. PubMed ID: 17015161
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
20. Perioperative daptomycin for prophylaxis of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
Mak JT; Ha S; Perloff S; Knorr JP
Transpl Infect Dis; 2024 Feb; 26(1):e14186. PubMed ID: 37910593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
